Synercid
- Product NDC
- 61570-260
- 11-digit product format
- 615700260
- Labeler code
- 61570
- Product ID
- 61570-260_e4ced767-b3af-4a33-845d-687ea3198695
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- quinupristin and dalfopristin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- NDA050748
- Marketing category
- NDA
- Marketing start
- 1999-09-21
- Marketing end
- 0000-00-00
- Substance
- DALFOPRISTIN; QUINUPRISTIN
- Active strength
- 350 mg/5mL; mg/5mL
- Pharmacologic classes
- Streptogramin Antibacterial [EPC], Streptogramin Antibacterial [EPC], Streptogramins [CS], Streptogramins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61570-260-10 | 61570026010 | 10 VIAL, GLASS in 1 CARTON (61570-260-10) > 5 mL in 1 VIAL, GLASS (61570-260-01) | 1999-09-21 | 0000-00-00 | No | No | Current |